Atlas Trials

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Clinical trial NCT06263348 · COMPLETED

Trial details

NCT number
NCT06263348
Sponsor
Hua Medicine Limited
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type2diabetes
Start date
2024-01-17
Primary completion
2025-12-31
Enrollment
2024

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.